Cleared Traditional

K914754 - MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL 540-D

K914754 is an FDA 510(k) clearance for MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL..., manufactured by Medtronic Bio-Medicus, Inc.. The device is a Class 2 Cardiovascular device with product code DWA cleared through the Traditional 510(k) pathway after a 211-day FDA review.

K914754 · Medtronic Bio-Medicus, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 1992
Decision
211d
Days
Class 2
Risk

K914754 is an FDA 510(k) clearance for the MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL 540-D. Classified as Control, Pump Speed, Cardiopulmonary Bypass (product code DWA), Class II - Special Controls.

Submitted by Medtronic Bio-Medicus, Inc. (Eden Prairie, US). The FDA issued a Cleared decision on May 20, 1992 after a review of 211 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4380 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K914754

510(k) Number K914754 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 22, 1991
Decision Date May 20, 1992
Days to Decision 211 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
86d slower than avg
Panel avg: 125d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DWA Device Classification - Class 2, Special Controls

Product Code DWA Control, Pump Speed, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4380
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWA Control, Pump Speed, Cardiopulmonary Bypass

All 35
Devices cleared under the same product code (DWA) and FDA review panel - the closest regulatory comparables to K914754.
MEDTRONIC BIO-MEDICUS HANDCRANK MODEL 150
K926357 · Medtronic Bio-Medicus, Inc. · Jun 1993
MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL 540E
K924206 · Medtronic Bio-Medicus, Inc. · May 1993
MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL 550
K924205 · Medtronic Bio-Medicus, Inc. · May 1993
BIO-MEDICUS BIO CONSOLE MODELS 540 A B C
K901584 · Bio Medicus, Inc. · Jun 1990
BIO MEDICUS BIO CONSOLE 540
K854133 · Bio Medicus, Inc. · Jan 1986
GAMBRO PULSATILE MONITOR PLM 10-200
K842503 · Gambro, Inc. · Aug 1984
K914754 · MEDTRONIC BIO-MEDICUS BIO-CONSOLE MODEL 540-D
Download PDF FDA Summary Medtronic Bio-Medicus…